RT3

RT3 40MG (R+D ONLY)

£174.99

RET 40MG (R+D ONLY) A novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors Key benefits Triple hormone receptor activation provides superior weight loss (24.2%), improved glycemic control, and enhanced cardiovascular benefits compared to single or dual agonists How it works (Mechanism) Activates GLP-1 for appetite suppression, GIP for insulin sensitivity, and glucagon for increased energy expenditure and hepatic fat oxidation Supplied exclusively as research material for controlled laboratory and analytical research. The product is not presented as a medicinal product, medical treatment, dietary supplement or therapeutic product. For research use only. Not for human or veterinary use. Not for consumption or administration.

• Supports cellular energy and mitochondrial function (Research Use Only)
• High purity (≥99%) – Third-party tested
• Raw lyophilized powder – Not for human consumption
• For laboratory research purposes only.

For research use only. Not for human consumption.